Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2023 Filed Apr 5, 2023 00:01 UTC |
Lewis TanyaChief Dev. Op. Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041720 · tm2311410-4_4seq1.xml · nonDerivative · entry 1 Lewis Tanya · CIK 0001451038 · Chief Dev. Op. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,360 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:04 UTC |
Pucci PaoloDirector
|
GrantStock Option (right to buy) · Derivative | 25,200 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041735 · tm2311410-14_4seq1.xml · derivative · entry 1 Pucci Paolo · CIK 0001436861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,200 Underlying: Common Stock · 25,200 shares Expires 2033-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2024. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 213,150 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041717 · tm2311410-1_4seq1.xml · derivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,150 Underlying: Common Stock · 213,150 shares Expires 2033-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
GrantCommon Stock | 142,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041717 · tm2311410-1_4seq1.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,543,180 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:03 UTC |
SLATTERY JOSEPH PDirector
|
GrantStock Option (right to buy) · Derivative | 25,200 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041732 · tm2311410-12_4seq1.xml · derivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,200 Underlying: Common Stock · 25,200 shares Expires 2033-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:03 UTC |
Levitsky HyamDirector
|
GrantStock Option (right to buy) · Derivative | 25,200 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041731 · tm2311410-11_4seq1.xml · derivative · entry 1 Levitsky Hyam · CIK 0001375792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,200 Underlying: Common Stock · 25,200 shares Expires 2033-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:01 UTC |
Love ColinChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041723 · tm2311410-5_4seq1.xml · derivative · entry 2 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:01 UTC |
Love ColinChief Operating Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041723 · tm2311410-5_4seq1.xml · nonDerivative · entry 1 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805,735 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:00 UTC |
Coffin RobertDirector · President & Chief R&D Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 67,500 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041718 · tm2311410-2_4seq1.xml · derivative · entry 2 Coffin Robert · CIK 0001376492 · Director · President & Chief R&D Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2033-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:00 UTC |
Coffin RobertDirector · President & Chief R&D Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041718 · tm2311410-2_4seq1.xml · nonDerivative · entry 1 Coffin Robert · CIK 0001376492 · Director · President & Chief R&D Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,841,197 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:01 UTC |
Franchi Jean M.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 67,500 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041725 · tm2311410-6_4seq1.xml · derivative · entry 2 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2033-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:01 UTC |
Franchi Jean M.Chief Financial Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041725 · tm2311410-6_4seq1.xml · nonDerivative · entry 1 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,099 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:04 UTC |
Slootweg Hugo AlexanderDirector
|
GrantStock Option (right to buy) · Derivative | 25,200 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041736 · tm2311410-15_4seq1.xml · derivative · entry 1 Slootweg Hugo Alexander · CIK 0001744922 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,200 Underlying: Common Stock · 25,200 shares Expires 2033-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2024. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:02 UTC |
Oliger Christy J.Director
|
GrantStock Option (right to buy) · Derivative | 25,200 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041728 · tm2311410-9_4seq1.xml · derivative · entry 1 Oliger Christy J. · CIK 0001822092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,200 Underlying: Common Stock · 25,200 shares Expires 2033-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2024. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:02 UTC |
Esposito PamelaChief Business Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041727 · tm2311410-8_4seq1.xml · derivative · entry 2 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:02 UTC |
Esposito PamelaChief Business Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041727 · tm2311410-8_4seq1.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,402 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 14, 2022 01:01 UTC |
Esposito PamelaChief Business Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001104659-22-126741 · tm2232604-1_4seq1.xml · derivative · entry 3 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,203 Underlying: Common Stock · 15,000 shares Expires 2025-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. Read SEC document |
| December 09, 2022 Filed Dec 14, 2022 01:01 UTC |
Esposito PamelaChief Business Officer
|
SaleCommon Stock | 15,000 | $25.03 | $375,450.00 |
DisclosureSEC source: 0001104659-22-126741 · tm2232604-1_4seq1.xml · nonDerivative · entry 2 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,402 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 13, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.14. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: Following the sales reported on this Form 4, the reporting person continues to beneficially own 229,402 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 477,227 shares of the Issuer's common stock, 378,400 of which are exercisable as of the date hereof. Read SEC document |
| December 09, 2022 Filed Dec 14, 2022 01:01 UTC |
Esposito PamelaChief Business Officer
|
Exercise / conversionCommon Stock | 15,000 | $1.01 | $15,150.00 |
DisclosureSEC source: 0001104659-22-126741 · tm2232604-1_4seq1.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 01:01 UTC |
Xynos KonstantinosChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,250 | $0.00 Strike: $19.98 | $0.00 |
DisclosureSEC source: 0001104659-22-124656 · tm2231933-2_4seq1.xml · derivative · entry 2 Xynos Konstantinos · CIK 0001956241 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2032-12-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on December 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 01:01 UTC |
Xynos KonstantinosChief Medical Officer
|
GrantCommon Stock | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-124656 · tm2231933-2_4seq1.xml · nonDerivative · entry 1 Xynos Konstantinos · CIK 0001956241 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,798 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on November 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until November 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:01 UTC |
Patel SushilChief Commercial Officer
|
SaleCommon Stock | 10,687 | $14.59 | $155,923.33 |
DisclosureSEC source: 0001104659-22-062607 · tm2215879-4_4seq1.xml · nonDerivative · entry 1 Patel Sushil · CIK 0001860609 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,146 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.59 to $14.62. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:02 UTC |
Lewis TanyaChief Dev. Op Officer
|
SaleCommon Stock | 5,473 | $14.59 | $79,851.07 |
DisclosureSEC source: 0001104659-22-062608 · tm2215879-5_4seq1.xml · nonDerivative · entry 1 Lewis Tanya · CIK 0001451038 · Chief Dev. Op Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,360 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.59 to $14.62. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
SaleCommon Stock | 9,632 | $14.59 | $140,530.88 |
DisclosureSEC source: 0001104659-22-062605 · tm2215879d2_4seq.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,401,080 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.57 to $14.59. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 16, 2022 Filed May 18, 2022 19:04 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 6,324 | $14.59 | $92,267.16 |
DisclosureSEC source: 0001104659-22-062611 · tm2215879-8_4seq1.xml · nonDerivative · entry 1 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 765,735 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.58 to $14.59. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 16, 2022 Filed May 18, 2022 19:01 UTC |
Coffin RobertDirector · President & Chief R&D Officer
|
SaleCommon Stock | 5,737 | $14.59 | $83,702.83 |
DisclosureSEC source: 0001104659-22-062606 · tm2215879d3_4seq.xml · nonDerivative · entry 1 Coffin Robert · CIK 0001376492 · Director · President & Chief R&D Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,796,197 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:03 UTC |
Franchi Jean M.Chief Financial Officer
|
SaleCommon Stock | 3,436 | $14.59 | $50,131.24 |
DisclosureSEC source: 0001104659-22-062609 · tm2215879-6_4seq1.xml · nonDerivative · entry 1 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,099 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.57 to $14.59. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:03 UTC |
Esposito PamelaChief Business Officer
|
SaleCommon Stock | 3,507 | $14.59 | $51,167.13 |
DisclosureSEC source: 0001104659-22-062610 · tm2215879-7_4seq1.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,402 F1 · shares: Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:16 UTC |
Patel SushilChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 78,750 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042768 · tm2211665-4_4seq1.xml · derivative · entry 2 Patel Sushil · CIK 0001860609 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:16 UTC |
Patel SushilChief Commercial Officer
|
GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042768 · tm2211665-4_4seq1.xml · nonDerivative · entry 1 Patel Sushil · CIK 0001860609 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,833 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:10 UTC |
Weinand DieterDirector
|
GrantStock Option (right to buy) · Derivative | 24,750 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042755 · tm2211665-11_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Underlying: Common Stock · 24,750 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:12 UTC |
Dhingra KapilDirector
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042758 · tm2211665-9_4seq1.xml · derivative · entry 1 Dhingra Kapil · CIK 0001456849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:09 UTC |
Pucci PaoloDirector
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042749 · tm2211665-13_4seq1.xml · derivative · entry 1 Pucci Paolo · CIK 0001436861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:15 UTC |
Lewis TanyaChief Dev.Op Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 78,750 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042765 · tm2211665-5_4seq1.xml · derivative · entry 2 Lewis Tanya · CIK 0001451038 · Chief Dev.Op Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:15 UTC |
Lewis TanyaChief Dev.Op Off
|
GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042765 · tm2211665-5_4seq1.xml · nonDerivative · entry 1 Lewis Tanya · CIK 0001451038 · Chief Dev.Op Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,833 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:18 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042773 · tm2211665-1_4seq1.xml · derivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:18 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042773 · tm2211665-1_4seq1.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,410,712 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:11 UTC |
SLATTERY JOSEPH PDirector
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042756 · tm2211665-10_4seq1.xml · derivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:08 UTC |
Levitsky HyamDirector
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042748 · tm2211665-14_4seq1.xml · derivative · entry 1 Levitsky Hyam · CIK 0001375792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:14 UTC |
Love ColinChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,375 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042760 · tm2211665-7_4seq1.xml · derivative · entry 2 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,375 Underlying: Common Stock · 39,375 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:14 UTC |
Love ColinChief Operating Officer
|
GrantCommon Stock | 26,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042760 · tm2211665-7_4seq1.xml · nonDerivative · entry 1 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 772,059 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:18 UTC |
Coffin RobertDirector · President & Chief R&D Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,375 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042771 · tm2211665-2_4seq1.xml · derivative · entry 2 Coffin Robert · CIK 0001376492 · Director · President & Chief R&D Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,375 Underlying: Common Stock · 39,375 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:18 UTC |
Coffin RobertDirector · President & Chief R&D Officer
|
GrantCommon Stock | 26,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042771 · tm2211665-2_4seq1.xml · nonDerivative · entry 1 Coffin Robert · CIK 0001376492 · Director · President & Chief R&D Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,801,934 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:13 UTC |
Rhodes Jason PDirector
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042759 · tm2211665-8_4seq1.xml · derivative · entry 1 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: This option was granted on April 1, 2022 with respect to 16,500 shares of the Issuer's common stock and vests in full on April 1, 2023. F2 · ownership.direct: This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:17 UTC |
Franchi Jean M.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 78,750 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042770 · tm2211665-3_4seq1.xml · derivative · entry 2 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:17 UTC |
Franchi Jean M.Chief Financial Officer
|
GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042770 · tm2211665-3_4seq1.xml · nonDerivative · entry 1 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,535 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:15 UTC |
Esposito PamelaChief Business Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 34,125 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042762 · tm2211665-6_4seq1.xml · derivative · entry 2 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,125 Underlying: Common Stock · 34,125 shares Expires 2032-04-01 F2 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:15 UTC |
Esposito PamelaChief Business Officer
|
GrantCommon Stock | 22,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042762 · tm2211665-6_4seq1.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,909 F1 · shares: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:10 UTC |
Slootweg Hugo AlexanderDirector
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042752 · tm2211665-12_4seq1.xml · derivative · entry 1 Slootweg Hugo Alexander · CIK 0001744922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:07 UTC |
Oliger Christy J.Director
|
GrantStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042747 · tm2211665-15_4seq1.xml · derivative · entry 1 Oliger Christy J. · CIK 0001822092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.